466 related articles for article (PubMed ID: 6285985)
1. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Miller OV; Ayer DE; Gorman RR
Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
[TBL] [Abstract][Full Text] [Related]
2. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
3. Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor).
Shaw JO; Klusick SJ; Hanahan DJ
Biochim Biophys Acta; 1981 Jan; 663(1):222-9. PubMed ID: 7213765
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
5. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
Gorman RR; Fitzpatrick FA; Miller OV
Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
[No Abstract] [Full Text] [Related]
8. Abnormal platelet response to thromboxane A2.
Wu KK; Le Breton GC; Tai HH; Chen YC
J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
[TBL] [Abstract][Full Text] [Related]
9. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function.
Fitzpatrick FA; Gorman RR
Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415
[TBL] [Abstract][Full Text] [Related]
10. Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.
Heffner JE; Shoemaker SA; Canham EM; Patel M; McMurtry IF; Morris HG; Repine JE
J Clin Invest; 1983 Feb; 71(2):351-7. PubMed ID: 6822668
[TBL] [Abstract][Full Text] [Related]
11. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
Gorman RR; Wierenga W; Miller OV
Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
[No Abstract] [Full Text] [Related]
12. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
Burns GB; Dodge JA
Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
[TBL] [Abstract][Full Text] [Related]
13. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
Bertele V; De Gaetano G
Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
[TBL] [Abstract][Full Text] [Related]
14. Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro.
Marcus AJ; Safier LB; Ullman HL; Wong KT; Broekman MJ; Weksler BB; Kaplan KL
Blood; 1981 Nov; 58(5):1027-31. PubMed ID: 6457658
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
[TBL] [Abstract][Full Text] [Related]
16. Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.
McManus LM; Pinckard RN; Fitzpatrick FA; O'Rourke RA; Crawford MH; Hanahan DJ
Lab Invest; 1981 Oct; 45(4):303-7. PubMed ID: 7300244
[TBL] [Abstract][Full Text] [Related]
17. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.
Fitzpatrick FA; Gorman RR
Biochim Biophys Acta; 1978 Mar; 539(2):162-72. PubMed ID: 629996
[TBL] [Abstract][Full Text] [Related]
18. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
[TBL] [Abstract][Full Text] [Related]
19. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.
McManus LM; Hanahan DJ; Pinckard RN
J Clin Invest; 1981 Mar; 67(3):903-6. PubMed ID: 7204562
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.
Gorman RR; Bundy GL; Peterson DC; Sun FF; Miller OV; Fitzpatrick FA
Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4007-11. PubMed ID: 269449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]